East West Bancorp Q2 Earnings Top on Higher NII & Non-Interest Income — Positive
EWBC Zacks Investment Research — July 23, 2025EWBC tops Q2 earnings estimates as net interest income and non-interest income rise. Loans and deposits also climb.
GameStop Stock Falls 10% in 3 Months: Time to Buy, Hold or Sell? — Negative
GME Zacks Investment Research — July 23, 2025The GME stock slumps 10% in 3 months as core sales sink despite cost cuts, collectibles gains and strong cash reserves.
Lucky Strike Entertainment (LUCK) Soars 9.2%: Is Further Upside Left in the Stock? — Positive
LUCK Zacks Investment Research — July 23, 2025Lucky Strike Entertainment (LUCK) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Fiserv Q2 Review: Clover Growth Fears Now Appear Overdone (Upgrade) — Positive
FI Seeking Alpha — July 23, 2025Fiserv, Inc.'s Q2 results showed slowing organic growth and margin expansion, intensifying market concerns despite strong cost controls and ongoing capital returns. Clover's growth deceleration and management's damaged credibility are key issues, but the platform remains a market share gainer with international and sector expansion potential. FI shares now reflect excessive pessimism, offering a 7% free cash flow yield and pricing in just 3% long-term growth, which I believe underestimates Fiserv's prospects.
McDonald's Snack Wrap demand causes lettuce shortage at some of its restaurants — Positive
MCD Fox Business — July 23, 2025After a nine-year hiatus, McDonald's brought back the popular Snack Wrap to overwhelming customer response, causing temporary ingredient shortages across some of its restaurants.
Can Organic Asset Expansion Fuel Energy Transfer's Long-Term Growth? — Positive
ET Zacks Investment Research — July 23, 2025ET plans to invest $5 billion in 2025 to expand its pipeline and storage network, boosting scale and export reach.
Enterprise Suite and Agentic AI: Can Intuit Win Mid-Market? — Positive
INTU Zacks Investment Research — July 23, 2025INTU rolls out AI agents in its Enterprise Suite, targeting mid-market firms with smarter, automated operations.
Pre-Markets Shine on Japanese Auto Trade Deal — Positive
HMC TM Zacks Investment Research — July 23, 2025A new trade agreement was announced that lowers tariffs on Japanese imported autos to +15% from +27.5%, with $550B in loans and investments.
Here's What to Expect From Pfizer's Non-Oncology Drugs in Q2 Earnings — Neutral
PFE Zacks Investment Research — July 23, 2025PFE's non-oncology portfolio draws focus in Q2, with strength in Vyndaqel and Nurtec offsetting some vaccine softness.
SAP's Q2 Earnings Beat Estimates, Revenues Miss, Stock Falls — Neutral
SAP Zacks Investment Research — July 23, 2025SAP posts 37% EPS growth and 24% cloud revenue surge, but shares slip after mixed Q2 results and currency concerns.
APLD Boosts Hyperscale Growth With 250MW AI Data Center Lease — Positive
APLD Zacks Investment Research — July 23, 2025Applied Digital inks a 250MW lease agreement with CoreWeave at Ellendale, cementing its role as a rising force in AI hyperscale infrastructure.
RCKT INVESTOR ALERT: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In RCKT To Contact Him Directly To Discuss Their Options — Neutral
RCKT PRNewsWire — July 23, 2025Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Rocket Pharmaceuticals To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $50,000 in Rocket Pharmaceuticals between February 27, 2025 and May 26, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK , July 23, 2025 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Rocket Pharmaceuticals, …
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Alto Neuroscience — Neutral
ANRO PRNewsWire — July 23, 2025Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Alto To Contact Him Directly To Discuss Their Options If you purchased or otherwise acquired stock of Alto (a) Alto common stock pursuant and/or traceable to the Offering Documents (defined below) issued in connection with the Company's initial public offering conducted on or about February 2, 2024 (the "IPO" or "Offering"); and/or (b) Alto securities between February 2, 2024 and October 22, 2024, both dates inclusive (the "Class Period") and would like to discuss your legal rights, call Faruqi & Faruqi partner …
Cryptocurrencies: Bitcoin Sets Another Record High — Positive
ARKB BITB BRRR ETHA ETHE ETHW EZET FBTC FETH GBTC IBIT ETF Trends — July 23, 2025This weekly update tracks some of the largest cryptocurrencies by market share: bitcoin and ether. While both are considered to be high-risk when it comes to investing, the two have foundational differences that investors should know.
In today's equity market, where a handful of mega-cap names continue to dominate index performance, many investors are reassessing how they gain exposure to large-cap equities. The traditional market-cap-weighted approach, while efficient, increasingly exposes portfolios to concentration risk.
Ascent Industries: Turnaround With Pure‑Play Specialty Chemicals Pivot — Positive
ACNT Seeking Alpha — July 23, 2025ACNT recently became a pure‑play chemical by divesting its legacy metal and tubular businesses in 2025. This process also integrates end‑to‑end workflow that should enhance time‑to‑market for new products and deepen customer relationships. Today, its broad specialty‑chemicals portfolio spans surfactants, defoamers, flame retardants, and oil & gas additives.
Thermo Fisher Q2 Earnings & Revenues Beat, Stock Up in Pre-Market — Positive
TMO Zacks Investment Research — July 23, 2025TMO tops Q2 estimates as new product launches and solid segment growth fuel revenue gains despite margin pressure.
EV Stock Faceoff: Is NIO's Mass Appeal Outshining LCID's Luxury Lane? — Neutral
LCID NIO Zacks Investment Research — July 23, 2025NIO gains ground with mass-market moves and rising margins, while LCID's luxury focus struggles to hit the accelerator.
First Community (FCCO) Tops Q2 Earnings and Revenue Estimates — Positive
FCCO Zacks Investment Research — July 23, 2025First Community (FCCO) came out with quarterly earnings of $0.67 per share, beating the Zacks Consensus Estimate of $0.58 per share. This compares to earnings of $0.42 per share a year ago.